Author

Kovács K

University of Pecs - Cited by 1,415

Biography

Dr. Katalin T. Kovács, a rheumatologist at our clinic, graduated in 2000 from the Faculty of General Medicine of the University of Pécs. He spent his residency in the Department of Immunology, the predecessor of the Clinic of Rheumatology and Immunology, where high-quality care for inflammatory rheumatological diseases became his heart's desire. After that, he strengthened the team of the Harkány Spa Hospital for a year and a half, where he took part in the treatment of various degenerative diseases (eg cartilage wear, calcification.
Title
Cited by
Year
Protective effects of the neuropeptide PACAP in diabetic retinopathy
K Szabadfi, T Atlasz, P Kiss, D Reglodi, A Szabo, K Kovacs, B Szalontai, ...Cell and tissue research 348 (1), 37-46, 2012201
82
2012
Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation
B Racz, K Hanto, A Tapodi, I Solti, N Kalman, P Jakus, K Kovacs, ...Free Radical Biology and Medicine 49 (12), 1978-1988, 2010201
77
2010
PACAP promotes neuron survival in early experimental diabetic retinopathy
K Szabadfi, A Szabo, P Kiss, D Reglodi, G Setalo Jr, K Kovacs, A Tamas, ...Neurochemistry international 64, 84-91, 2014201
74
2014
Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases
A Szabo, K Sumegi, K Fekete, E Hocsak, B Debreceni, G Setalo Jr, ...Biochemical pharmacology 150, 86-96, 2018201
66
2018
Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt
T Kiss, K Kovacs, A Komocsi, A Tornyos, P Zalan, B Sumegi, F Gallyas Jr, ...PloS one 9 (8), e104890, 2014201
56
2014
Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion
A Szabo, B Danyadi, E Bognar, K Szabadfi, E Fabian, P Kiss, L Mester, ...Neuroscience Letters 3 (2), 93-98, 2012201
52
2012
Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress
E Fabian, D Reglodi, L Mester, A Szabo, K Szabadfi, A Tamas, G Toth, ...Journal of Molecular Neuroscience 48, 3-500, 2012201
49
2012
Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells
G Horvath, R Brubel, K Kovacs, D Reglodi, B Opper, A Ferencz, P Szakaly, ...Journal of Molecular Neuroscience 43, 67-75, 2011201
47
2011
Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy
E Banki, P Degrell, P Kiss, K Kovacs, A Kemeny, K Csanaky, A Duh, ...Peptides 42, 125-130, 2013201
41
2013
Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury
P Szakaly, E Laszlo, K Kovacs, B Racz, G Horvath, A Ferencz, A Lubics, ...Neuropeptides 45 (2), 113-121, 2011201
39
2011
Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells
L Mester, K Kovacs, B Racz, I Solti, T Atlasz, K Szabadfi, A Tamas, ...Journal of Molecular Neuroscience 43, -43, 2011201
35
2011
PARP inhibitor protects against chronic hypoxia/reoxygenation-induced retinal injury by regulation of MAPKs, HIF1α, Nrf2, and NFκB
K Kovacs, A Vaczy, K Fekete, P Kovari, T Atlasz, D Reglodi, R Gabriel, ...Investigative Ophthalmology & Visual Science 60 (5), 1478-1490, 2019201
33
2019
Accelerated pre‐senile systemic amyloidosis in PACAP knockout mice–a protective role of PACAP in age‐related degenerative processes
D Reglodi, A Jungling, R Longuespée, J Kriegsmann, R Casadonte, ...The Journal of pathology 245 (4), 478-490, 2018201
33
2018
Ocular delivery of PACAP1-27 protects the retina from ischemic damage in rodents
D Werling, D Reglodi, WA Banks, TS Salameh, K Kovacs, T Kvarik, ...Investigative ophthalmology & visual science 57 (15), 6683-6691, 2016201
29
2016
Molecular mechanisms underlying the nephroprotective effects of PACAP in diabetes
E Banki, K Kovacs, D Nagy, T Juhasz, P Degrell, K Csanaky, P Kiss, ...Journal of Molecular Neuroscience 54, 300-309, 2014201
29
2014
Galectin-3 is an independent predictor of survival in systemic sclerosis
R Faludi, G Nagy, M Tőkés-Füzesi, K Kovács, L Czirják, A KomócsiInternational Journal of Cardiology 233, 118-124, 2017201
26
2017
Neuroprotective effects of PACAP in the retina
T Atlasz, A Vaczy, D Werling, P Kiss, A Tamas, K Kovacs, E Fabian, ...Springer Nature, pp. 501-527, 201624201
24
2016
The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
AT Vaczy A, Reglodi D, Somoskeoy T, Kovacs K, Lokos E, Szabo E, Tamas AJ Mol Neurosci, 2016201
23
2016
Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice
RD Laszlo E, Varga A, Kovacs K, Jancso G, Kiss P, Tamas A, Szakaly P, Fulop BTransplant Proc. 47 (7), 10-15, 2015201
22
2015
PACAP Is Protective in a Rat Model of Retinopathy of Prematurity
AT Kvarik T, Mammel B, Reglodi D, Kovacs K, Werling D, Bede B, Vaczy A ...J Mol Neurosci, 161
20
2016

Referred From: https://scholar.google.com/citations?user=dhbu-gcAAAAJ&hl=en

Cited by
Citations 1415
h-index 24
i10-index 34
Open Access Journals